The cost of Ubrelvy (ubrogepant) varies depending on insurance coverage, dosage, and pharmacy. Without insurance, a 30-day supply can range from approximately $800 to over $1,000 [1].
How much does Ubrelvy cost with insurance?
Insurance coverage for Ubrelvy significantly impacts the out-of-pocket cost. Many insurance plans offer Ubrelvy at a reduced price, with copays sometimes as low as $10 or $20 per prescription. However, the exact copay amount is determined by individual insurance policies and formulary status [1]. Ubrelvy's manufacturer also offers a savings card that may reduce copays for eligible commercially insured patients to as low as $0 [1].
What factors influence Ubrelvy pricing?
Several factors contribute to the overall cost of Ubrelvy. These include the drug's list price, pharmacy dispensing fees, and the patient's insurance plan benefits, such as deductibles, copays, and coinsurance. The specific dosage of Ubrelvy prescribed also affects the total cost, as higher doses or more frequent use will increase expenses [1].
Are there Ubrelvy patient assistance programs?
Yes, Ubrelvy has patient assistance programs designed to help reduce the financial burden for eligible individuals. The Ubrelvy Savings Card can lower copayments for those with commercial insurance. For uninsured or underinsured patients, manufacturer-sponsored patient assistance programs may offer further financial support, although eligibility requirements apply [1].
How does Ubrelvy's price compare to other migraine treatments?
The pricing of Ubrelvy can be compared to other acute migraine treatments, including triptans and other CGRP antagonists. The cost-effectiveness often depends on individual patient needs, treatment response, and insurance coverage for each specific medication. Some older generic migraine medications may be less expensive than newer branded options like Ubrelvy [1].
When does Ubrelvy's patent expire?
Information regarding the specific patent expiration dates for Ubrelvy is available through patent tracking services [2]. Understanding patent exclusivity is crucial for predicting when generic versions might become available, potentially leading to lower prices.
What is Ubrelvy approved for?
Ubrelvy is approved for the acute treatment of migraine with or without aura in adults [1].
---
1. Ubrelvy. GoodRx. https://www.goodrx.com/ubrelvy
2. DrugPatentWatch.com. https://drugpatentwatch.com/